639 related articles for article (PubMed ID: 2969000)
1. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
[TBL] [Abstract][Full Text] [Related]
2. The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
Cozzolino D; Sessa G; Salvatore T; Sasso FC; Giugliano D; Lefebvre PJ; Torella R
J Clin Endocrinol Metab; 1996 Feb; 81(2):713-8. PubMed ID: 8636293
[TBL] [Abstract][Full Text] [Related]
3. Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects.
Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Torella R; Franchimont P; Lefebvre PJ; D'Onofrio F
Metabolism; 1992 Feb; 41(2):184-90. PubMed ID: 1736041
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
[TBL] [Abstract][Full Text] [Related]
5. Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity.
Giugliano D; Cozzolino D; Torella R; Lefebvre PJ; Franchimont P; D'Onofrio F
Acta Endocrinol (Copenh); 1991 Feb; 124(2):159-65. PubMed ID: 2003375
[TBL] [Abstract][Full Text] [Related]
6. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs.
el-Tayeb KM; Vranic M; Brubaker PL; Lickley HL
Diabetologia; 1987 Sep; 30(9):745-54. PubMed ID: 2962893
[TBL] [Abstract][Full Text] [Related]
7. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man.
Paolisso G; Giugliano D; Scheen AJ; Franchimont P; D'Onofrio F; Lefèbvre PJ
Acta Endocrinol (Copenh); 1987 Jun; 115(2):161-9. PubMed ID: 2885994
[TBL] [Abstract][Full Text] [Related]
8. Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent.
Giugliano D; Cozzolino D; Salvatore T; Torella R; D'Onofrio F
Diabetes; 1988 Sep; 37(9):1265-70. PubMed ID: 2970411
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
Eigler N; Saccà L; Sherwin RS
J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
[TBL] [Abstract][Full Text] [Related]
10. Beta-endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in normal dogs.
el-Tayeb KM; Brubaker PL; Vranic M; Lickley HL
Diabetes; 1985 Dec; 34(12):1293-300. PubMed ID: 2998913
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to beta-endorphin as a cause of human obesity.
Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
Metabolism; 1987 Oct; 36(10):974-8. PubMed ID: 2958673
[TBL] [Abstract][Full Text] [Related]
12. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
13. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
14. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
[TBL] [Abstract][Full Text] [Related]
15. [Beta-endorphin and obesity. Possible pathogenetic implications].
Giugliano D; Saccomanno F; Quatraro A; Ceriello A; Torella R
Minerva Endocrinol; 1990; 15(2):149-51. PubMed ID: 2098658
[TBL] [Abstract][Full Text] [Related]
16. The effect of beta-endorphin on biogenic amines, insulin, and glucagon levels in the hepatic portal circulation of normal and pancreatectomized dogs.
Hussain MN; Kikuchi K; Cukerman E; Sirek A; Sirek OV
Endocrinology; 1986 Aug; 119(2):685-90. PubMed ID: 2942391
[TBL] [Abstract][Full Text] [Related]
17. Insulin and glucagon responses to adrenaline infusion in abdominal obese men.
Mauriège P; Klein Kranenbarg WM; Prud'homme D; Lamarche B; Tremblay A; Bouchard C; Nadeau A; Després JP
Int J Obes Relat Metab Disord; 1996 Jul; 20(7):668-76. PubMed ID: 8817361
[TBL] [Abstract][Full Text] [Related]
18. Influence of insulin on beta-endorphin plasma levels in obese and normal weight subjects.
Brunani A; Pincelli AI; Pasqualinotto L; Tibaldi A; Baldi G; Scacchi M; Fatti LM; Cavagnini F
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):710-4. PubMed ID: 8856392
[TBL] [Abstract][Full Text] [Related]
19. Beta-endorphin plasma levels and their dependence on gender during an enteral glucose load in lean subjects as well as in obese patients before and after weight reduction.
Ritter MM; Sönnichsen AC; Möhrle W; Richter WO; Schwandt P
Int J Obes; 1991 Jun; 15(6):421-7. PubMed ID: 1885266
[TBL] [Abstract][Full Text] [Related]
20. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
